Mutations in the HFE gene and sporadic amyotrophic lateral sclerosis risk: A meta-analysis of observational studies

Brazilian Journal of Medical and Biological Research

Volumn 47, Issue 3, 2014, Pages 215-222

  Li, M ^a   Wang, L ^a   Wang, W ^a   Qi, X L ^a   Tang, Z Y ^a  

^a NANCHANG UNIVERSITY   (China)

Author keywords

Amyotrophic lateral sclerosis; C282Y; H63D; HFE; Meta analysis; Polymorphism

Indexed keywords

HFE PROTEIN; HFE PROTEIN, HUMAN; HLA ANTIGEN CLASS 1; IRON; MEMBRANE PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; GENE MUTATION; GENETIC POLYMORPHISM; HOMEOSTASIS; HUMAN; IRON HOMEOSTASIS; META ANALYSIS; RISK; SENSITIVITY ANALYSIS; CAUCASIAN; GENETIC ASSOCIATION; GENETICS; METABOLISM; MUTATION; OBSERVATIONAL STUDY; PROTECTION; RISK FACTOR;

AMYOTROPHIC LATERAL SCLEROSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC ASSOCIATION STUDIES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IRON; MEMBRANE PROTEINS; MUTATION; OBSERVATIONAL STUDY AS TOPIC; ODDS RATIO; POLYMORPHISM, GENETIC; PROTECTIVE FACTORS; RISK FACTORS;

EID: 84898860132     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/1414-431X20133296     Document Type: Article

References (37)

1. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996; 13: 399-408. doi: 10.1038/ng0896-399
2. Wang XS, Lee S, Simmons Z, Boyer P, Scott K, Liu W, et al. Increased incidence of the Hfe mutation in amyotrophic lateral sclerosis and related cellular consequences. J Neurol Sci 2004; 227: 27-33. doi: 10.1016/j.jns.2004.08.003
3. Mitchell RM, Lee SY, Randazzo WT, Simmons Z, Connor JR. Influence of HFE variants and cellular iron on monocyte chemoattractant protein-1. J Neuroinflammation 2009; 6: 6. doi: 10.1186/1742-2094-6-6
4. Santos PC, Krieger JE, Pereira AC. Molecular diagnostic and pathogenesis of hereditary hemochromatosis. Int J Mol Sci 2012; 13: 1497-1511. doi: 10.3390/ijms13021497
5. Kaur H, Halliwell B. Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients. FEBS Lett 1994; 350: 9-12. doi: 10.1016/0014-5793(94)00722-5
6. Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N Engl J Med 2001; 344: 1688-1700. doi: 10.1056/NEJM 200105313442207
7. Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman OM. Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: A population-based study. Arch Neurol 2000; 57: 1171-1176. doi: 10.1001/archneur.57.8.1171
8. Hardiman O, van den Berg LH, Kiernan MC. Clinical diagnosis and management of amyotrophic lateral sclerosis. Nat Rev Neurol 2011; 7: 639-649. doi: 10.1038/nrneurol. 2011.153
9. Cudkowicz ME, Kenna-Yasek D, Sapp PE, Chin W, Geller B, Hayden DL, et al. Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis. Ann Neurol 1997; 41: 210-221. doi: 10.1002/ana.410410212
10. Njajou OT, Houwing-Duistermaat JJ, Osborne RH, Vaessen N, Vergeer J, Heeringa J, et al. A population-based study of the effect of the HFE C282Y and H63D mutations on iron metabolism. Eur J Hum Genet 2003; 11: 225-231. doi: 10.1038/sj.ejhg.5200955
11. Kwan JY, Jeong SY, van Gelderen P, Deng HX, Quezado MM, Danielian LE, et al. Iron accumulation in deep cortical layers accounts for MRI signal abnormalities in ALS: correlating 7 tesla MRI and pathology. PLoS One 2012; 7: e35241. doi: 10.1371/journal.pone.0035241
12. Rothstein JD. Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann Neurol 2009; 65 (Suppl 1): S3-S9. doi: 10.1002/ana.21543
13. Praline J, Blasco H, Vourc'h P, Rat V, Gendrot C, Camu W, et al. Study of the HFE gene common polymorphisms in French patients with sporadic amyotrophic lateral sclerosis. J Neurol Sci 2012; 317: 58-61. doi: 10.1016/j.jns.201202.029
14. Sutedja NA, Sinke RJ, Van Vught PW, Van der Linden MW, Wokke JH, van Duijn CM, et al. The association between H63D mutations in HFE and amyotrophic lateral sclerosis in a Dutch population. Arch Neurol 2007; 64: 63-67. doi: 10.1001/archneur.64.1.63
15. Yen AA, Simpson EP, Henkel JS, Beers DR, Appel SH. HFE mutations are not strongly associated with sporadic ALS. Neurology 2004; 62: 1611-1612. doi: 10.1212/01. WNL.0000123114.04644.CC.
16. Restagno G, Lombardo F, Ghiglione P, Calvo A, Cocco E, Sbaiz L, et al. HFE H63D polymorphism is increased in patients with amyotrophic lateral sclerosis of Italian origin. J Neurol Neurosurg Psychiatry 2007; 78: 327. doi: 10.1136/ jnnp.2006.092338
17. Goodall EF, Greenway MJ, van Marion I, Carroll CB, Hardiman O, Morrison KE. Association of the H63D polymorphism in the hemochromatosis gene with sporadic ALS. Neurology 2005; 65: 934-937. doi: 10.1212/01.wnl. 0000176032.94434.d4
18. van Rheenen W, Diekstra FP, van Doormaal PT, Seelen M, Kenna K, McLaughlin R, et al. H63D polymorphism in HFE is not associated with amyotrophic lateral sclerosis. Neurobiol Aging 2013; 34: 1517. doi: 10.1016/j.neurobiolaging.201207.020
19. Ellervik C, Birgens H, Tybjaerg-Hansen A, Nordestgaard BG. Hemochromatosis genotypes and risk of 31 disease endpoints: meta-analyses including 66,000 cases and 226,000 controls. Hepatology 2007; 46: 1071-1080. doi: 10.1002/hep.21885
20. Lill CM, Abel O, Bertram L, Al-Chalabi A. Keeping up with genetic discoveries in amyotrophic lateral sclerosis: the ALSoD and ALSGene databases. Amyotroph Lateral Scler 2011; 12: 238-249. doi: 10.3109/17482968.2011.584629
21. Merryweather-Clarke AT, Pointon JJ, Jouanolle AM, Rochette J, Robson KJ. Geography of HFE C282Y and H63D mutations. Genet Test 2000; 4: 183-198. doi: 10.1089/10906570050114902
22. Pointon JJ, Merryweather-Clarke AT, Carella M, Robson KJ. Detection of C282Y and H63D in the HFE gene. Genet Test 2000; 4: 115-120. doi: 10.1089/10906570050114803
23. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188. doi: 10.1016/0197- 2456(86)90046-2
24. DerSimonian R, Kacker R. Random-effects model for metaanalysis of clinical trials: an update. Contemp Clin Trials 2007; 28: 105-114. doi: 10.1016/j.cct.2006.04.004
25. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719-748
26. Pietrangelo A. Hereditary hemochromatosis - a new look at an old disease. N Engl J Med 2004; 350: 2383-2397. doi: 10.1056/NEJMra031573
27. Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634. doi: 10.1136/bmj.315.7109.629
28. He X, Lu X, Hu J, Xi J, Zhou D, Shang H, et al. H63D polymorphism in the hemochromatosis gene is associated with sporadic amyotrophic lateral sclerosis in China. Eur J Neurol 2011; 18: 359-361. doi: 10.1111/j.1468-1331.201003158.x.
29. Munafo MR, Flint J. Meta-analysis of genetic association studies. Trends Genet 2004; 20: 439-444. doi: 10.1016/ j.tig.2004.06.014
30. Santos PC, Cancado RD, Terada CT, Rostelato S, Gonzales I, Hirata RD, et al. HFE gene mutations and iron status of Brazilian blood donors. Braz J Med Biol Res 2010; 43: 107-114. doi: 10.1590/S0100-879X2009007500031
31. Egger M, Smith GD. Bias in location and selection of studies. BMJ 1998; 316: 61-66. doi: 10.1136/bmj.316.7124.61
32. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-1101. doi: 10.2307/2533446
33. Sutton AJ, Duval SJ, Tweedie RL, Abrams KR, Jones DR. Empirical assessment of effect of publication bias on metaanalyses. BMJ 2000; 320: 1574-1577. doi: 10.1136/ bmj.320.7249.1574
34. Sterne JA, Gavaghan D, Egger M. Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol 2000; 53: 1119-1129. doi: 10.1016/S0895-4356(00)00242-0
35. Schmidt S, Allen KD, Loiacono VT, Norman B, Stanwyck CL, Nord KM, et al. Genes and Environmental Exposures in Veterans with Amyotrophic Lateral Sclerosis: the GENEVA study. Rationale, study design and demographic characteristics. Neuroepidemiology 2008; 30: 191-204. doi: 10.1159/ 000126911
36. Santos PC, Cancado RD, Pereira AC, Schettert IT, Soares RA, Pagliusi RA, et al. Hereditary hemochromatosis: mutations in genes involved in iron homeostasis in Brazilian patients. Blood Cells Mol Dis 2011; 46: 302-307. doi: 10.1016/j.bcmd.2011.02.008
37. Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJ. Global prevalence of putative haemochromatosis mutations. J Med Genet 1997; 34: 275-278. doi: 10.1136/jmg.34.4.275.